Which eight escaped the Scientific 16?
The Journal of Biological Chemistry’s Methods Madness tournament started off with a bang as last year’s finalist, , faced off against the tournament newcomer . fought valiantly, but their supporters’ energy just didn’t transfer into votes. Meanwhile, supporters turned up in SPECTRAcular numbers, pushing their team to the next round.
X-ray crystallographers around the world are rejoicing after ’s victory over . Votes proved to be too nonspecific for , whose supporters were unable to band together to provide support for their team. advances to the next round while fades into the background.
iced their competition, leaving #TeamMachine frozen in their tracks. Despite strategic support from , it seems too many #TeamMachine supporters had their heads in the cloud, because they couldn’t find the algorithm needed to execute a win against the defending champion. will move on to the Energetic Eight, where they will have a tough matchup against .
In this cellular showdown, lacked the factors necessary to differentiate from the other losers of the week. In contrast, was unphased by the pressure, shining bright in the win they captured. has in their frame as they focus on the next round.
copied last year’s success to defeat and advance to the next round. Supporters of #TeamChroma couldn’t match the flow rate of voters, leaving stuck in a stationary phase while their opponent mobilized. will look to amplify their success with a win over in the next round.
Resonating with their supporters, put forth a dynamic performance to secure their second win in as many years. Living up to their name, replicated last year’s performance where they also lost against in the first round. Perhaps they’ll find the winning recombination next year!
excised in the first round of the tournament and will move on to the next round. Despite their resolution to make it further this year, the win that pictured was never fully deconvolved. has their work cut out for them, facing off against the defending champion #TeamCryo.
Seq-ing a win in their tournament debut, analyzed their competition and came out victorious. Seemingly unable to shed light on a winning formula, failed to excite their supporters, resulting in their second tournament loss in as many years. Next, will match up against in the Energetic Eight round.
Round 2: The Energetic Eight
Monday, March 22
12 p.m. Eastern – #TeamNMR vs. #TeamXRC
Tuesday, March 23
12 p.m. Eastern – #TeamPCR vs. #TeamMassSpec
Wednesday, March 24
12 p.m. – #TeamLiveCell vs. #TeamOmics
Thursday, March 25
12 p.m. – #TeamCryo vs. #TeamCRISPR
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Guiding grocery carts to shape healthy habits
Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Quantifying how proteins in microbe and host interact
“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.
Leading the charge for gender equity
Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
CRISPR gene editing: Moving closer to home
With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.
Finding a missing piece for neurodegenerative disease research
Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.
From the journals: JLR
Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.